Circio Holding ASA
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a … Read more
Circio Holding ASA (CRNA) - Total Assets
Latest total assets as of June 2025: Nkr12.75 Million NOK
Based on the latest financial reports, Circio Holding ASA (CRNA) holds total assets worth Nkr12.75 Million NOK as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Circio Holding ASA - Total Assets Trend (2020–2024)
This chart illustrates how Circio Holding ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Circio Holding ASA - Asset Composition Analysis
Current Asset Composition (December 2024)
Circio Holding ASA's total assets of Nkr12.75 Million consist of 99.1% current assets and 0.9% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr17.84 Million | 83.4% |
| Accounts Receivable | Nkr0.00 | 0.0% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr185.00K | 0.9% |
| Intangible Assets | Nkr5.00K | 0.0% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Circio Holding ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Circio Holding ASA's current assets represent 99.1% of total assets in 2024, an increase from 24.4% in 2020.
- Cash Position: Cash and equivalents constituted 83.4% of total assets in 2024, up from 0.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 74.0% in 2020.
- Asset Diversification: The largest asset category is cash and equivalents at 83.4% of total assets.
Circio Holding ASA Competitors by Total Assets
Key competitors of Circio Holding ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Circio Holding ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Circio Holding ASA generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Circio Holding ASA generates $ 263.50 in net profit.
Circio Holding ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.50 | 0.12 | 3.14 |
| Quick Ratio | 0.50 | 0.12 | 3.14 |
| Cash Ratio | 0.25 | 0.05 | 2.88 |
| Working Capital | Nkr-12.58 Million | Nkr -48.16 Million | Nkr 93.53 Million |
Circio Holding ASA - Advanced Valuation Insights
This section examines the relationship between Circio Holding ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.77 |
| Asset Growth Rate (YoY) | -15.1% |
| Total Assets | Nkr21.83 Million |
| Market Capitalization | $16.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Circio Holding ASA's assets below their book value (0.77 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Circio Holding ASA's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Circio Holding ASA (2020–2024)
The table below shows the annual total assets of Circio Holding ASA from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr21.83 Million | -15.10% |
| 2023-12-31 | Nkr25.71 Million | -74.39% |
| 2022-12-31 | Nkr100.41 Million | -82.24% |
| 2021-12-31 | Nkr565.27 Million | +8.55% |
| 2020-12-31 | Nkr520.74 Million | -- |